Enhancement of anxiety-like responsiveness to the cannabinoid CB 1 receptor agonist HU-210 following chronic stress

European Journal of Pharmacology

Volumn 499, Issue 3, 2004, Pages 291-295

  Hill, Matthew N ^a   Gorzalka, Boris B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

(Rat); Anxiety; Cannabinoid; Chronic stress; Elevated plus maze

Indexed keywords

CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DEXANABINOL;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STRESS; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; RATS; RATS, LONG-EVANS; RECEPTOR, CANNABINOID, CB1; STRESS; TETRAHYDROCANNABINOL;

EID: 4544383665     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.06.069     Document Type: Article

References (20)

1. S.L. Ablon, and F.K. Goodwin High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients Am. J. Psychiatry 131 1974 448 453
2. F. Berrendero, and R. Maldonado Involvement of the opioid system in the anxiolytic-like effects induced by Î"9-tetrahydrocannabinol Psychopharmacology 163 2002 111 117
3. P.S. d'Aquila, P. Brain, and P. Willner Effects of chronic mild stress on performance in behavioural tests relevant to anxiety and depression Physiol. Behav. 56 1994 861 867
4. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol. Rev. 83 2003 1017 1066
5. J.M. Gregg, E.W. Small, R. Moore, D. Raft, and T.C. Toomey Emotional response to intravenous Î"9-tetrahydrocannabinol during oral surgery J. Oral Surg. 34 1976 301 313
6. J. Haller, N. Bakos, M. Szirmay, C. Ledent, and T.F. Freund The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety Eur. J. Neurosci. 16 2002 1395 1398
7. M. Herkenham, A.B. Lynn, M.R. Johnson, L.S. Melvin, B.R. de Costa, and K.C. Rice Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J. Neurosci. 11 1991 563 583
8. M.N. Hill, E.J. Carrier, S. Patel, B.K. Ormerod, C.J. Hillard, and B.B. Gorzalka Chronic stress elicits differential regulation of cannabinoid type 1 (CB1) receptor binding and expression in the hippocampus and limbic forebrain Abstr.-Soc. Neurosci. 829.18 2003
9. L.E. Hollister Health aspects of cannabis Pharmacol. Rev. 38 1986 1 20
10. S. Kathuria, S. Gaetani, D. Fegley, F. Valino, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. La Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, and D. Piomelli Modulation of anxiety through blockade of anandamide hydrolysis Nat. Med. 9 2003 76 81
11. J.P. McLaughlin, M. Marton-Popovici, and C. Chavkin Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses J. Neurosci. 23 2003 5674 5683
12. K.I. MacLean, and J.M. Littleton Environmental stress as a factor in the response of rat brain catecholamine metabolism to Î"8- tetrahydrocannabinol Eur. J. Pharmacol. 41 1977 171 182
13. S. Marin, E. Marco, M. Biscaia, B. Fernandez, M. Rubio, C. Guaza, H. Schmidhammer, and M.P. Viveros Involvement of the κ-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats Pharmacol. Biochem. Behav. 74 2003 649-656
14. M. Martin, C. Ledent, M. Parmentier, R. Maldonado, and O. Valverde Involvement of CB1 cannabinoid receptors in emotional behavior Psychopharmacology 159 2002 379 387
15. M. Navarro, E. Hernandez, R.M. Munoz, I. del Arco, M.A. Villanua, M.R.A. Carrera, and F. Rodriguez de Fonseca Acute administration of the CB1 cannabinoid receptor antagonist SR-141716A induces anxiety-like responses in the rat NeuroReport 8 1997 491 496
16. E.S. Onaivi, M.R. Green, and B.R. Martin Pharmacological characterization of cannabinoids in the elevated plus maze J. Pharmacol. Exp. Ther. 253 1990 1002 1009
17. F. Rodriguez de Fonseca, P. Rubio, F. Menzaghi, E. Merlo-Pich, J. Rivier, G.F. Koob, and M. Navarro Corticotropin-releasing factor (CRF) antagonist [d-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats J. Pharmacol. Exp. Ther. 276 1996 56 64
18. J.A. Talbott, and J.W. Teague Marihuana psychosis J. Am. Med. Assoc. 210 1969 299
19. A. Vyas, R. Mitra, B.S. Shankaranarayana Rao, and S. Chattarji Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons J. Neurosci. 22 2002 6810 6818
20. A. Zimmer, E. Valjent, M. Konig, A.M. Zimmer, P. Robledo, H. Hahn, O. Valverde, and R. Maldonado Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin deficient mice J. Neurosci. 21 2001 9499 9505